Document is current
Any future updates will be listed below
-
Authors
Li, Chunwang
Huang, Shuna
Li, Qixuan
Zhuo, Lingyun
Kang, Yaqing
Liu, Penghui
Huang, Weilin
Ma, Ke
Lin, Xinru
Zhuang, Weiheng
Chen, Darong
Wang, Huimin
Yan, Lingjun
Wang, Dengliang
Lin, Yuanxiang
Kang, Dezhi
Lin, Fuxin
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct03467295 at ClinicalTrials.govDocuments that mention this clinical trial
Prevalence, genetic and clinical characteristics in first-degree relatives of patients with familial cerebral cavernous malformations in China
https://doi.org/10.1136/svn-2023-003004
Plasma biomarkers in patients with familial cavernous malformation and their first-degree relatives: a cross-sectional study
https://doi.org/10.1038/s41598-025-91141-6
Treatments and outcomes of untreated cerebral cavernous malformations in China: study protocol of a nationwide multicentre prospective cohort study (Pre-results)
https://doi.org/10.1136/bmjopen-2020-037957
-
Funding
Funding for this research was provided by:
Technology Platform Construction Project of Fujian Province (2020Y2003)
the Government of Fujian Province (HLNCC-FJFY-003)
- License Information
-
More Information
Article History
Received: 7 June 2024
Accepted: 18 February 2025
First Online: 2 April 2025
Declarations
:
: The authors declare no competing interests.
